You have 9 free searches left this month | for more free features.

PDL1

Showing 1 - 25 of 745

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact

Not yet recruiting
  • PDL1- Colorectal Carcinoma
    • (no location specified)
    Jan 11, 2023

    Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT

    Recruiting
    • Lung Cancer Stage III
    • Lung Cancer Stage IV
      • Brest, France
        Chu Brest
      Aug 16, 2023

      HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With

      Not yet recruiting
      • Gastric Cancer
      • Observational
      • (no location specified)
      Dec 13, 2022

      Multiple Myeloma Trial (Bone marow biopsy and aspiration, biochemical and heamatological tests)

      Not yet recruiting
      • Multiple Myeloma
      • Bone marow biopsy and aspiration
      • biochemical and heamatological tests
      • (no location specified)
      Aug 9, 2023

      Skin Health and Quality of Life in Patients Receiving

      Not yet recruiting
      • Lung Cancer
      • +7 more
      • EQ-5D-5L questionnaire
      • +2 more
      • Roma, Italy
        Roberto Iacovelli
      May 17, 2023

      NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • Phase I - Mirdametinib - Level 1
      • +4 more
      • (no location specified)
      Jul 7, 2023

      Advanced Tumors, Lymphoma, Metastatic Tumors Trial in Changchun, Jinan (HLX301)

      Recruiting
      • Advanced Tumors
      • +2 more
      • Changchun, Jilin, China
      • +1 more
      Jul 12, 2022

      NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • +4 more
      • MK-2870
      • +2 more
      • (no location specified)
      Sep 15, 2023

      Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

      Recruiting
      • Solid Tumor Malignancy
      • +4 more
      • mRNA-1273
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 14, 2023

      PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC

      Recruiting
      • Non-small Cell Lung Cancer
      • Monza, Italy
        ASST-Monza Ospedale San Gerardo
      Jun 9, 2022

      Advanced Gastroesophageal Adenocarcinoma, First-line Therapy, PDL1 CPS < 5 Trial (CAPOX combined with bevacizumab and

      Not yet recruiting
      • Advanced Gastroesophageal Adenocarcinoma
      • +2 more
      • CAPOX combined with bevacizumab and Tislelizumab
      • (no location specified)
      Mar 17, 2022

      NSCLC, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma Trial in San Antonio, West Valley City,

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +4 more
      • San Antonio, Texas
      • +2 more
      Aug 15, 2022

      Acute Lymphoblastic Leukemia in Pediatric Trial in Sohag (flow cytometric immunophynotyping)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia in Pediatric
      • flow cytometric immunophynotyping
      • Sohag, Egypt
        Sohag University Hospital
      Jun 19, 2022

      SOX2 & PDL1 Expression on Urinary Bladder Carcinoma

      Not yet recruiting
      • Urinary Bladder Neoplasm
        • (no location specified)
        Jun 17, 2022

        Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for

        Not yet recruiting
        • Primary Hepatocellular Carcinoma
        • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
        • camrelizumab for Injection
        • (no location specified)
        Nov 13, 2023

        Locally Advanced or Metastatic Solid Tumors, NSCLC Trial in Australia (HLX301)

        Recruiting
        • Locally Advanced or Metastatic Solid Tumors
        • Non-small Cell Lung Cancer
        • Blacktown, New South Wales, Australia
        • +4 more
        May 25, 2022

        Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)

        Not yet recruiting
        • Cervical Cancer
        • Recombinant humanized anti-PD-1 monoclonal antibody injection
        • +4 more
        • Wuhan, Hubei, China
          Tongji Hospital affiliated to Tongji Medical College of Huazhong
        Nov 3, 2023

        Urothelial Carcinoma Trial in Ann Arbor (Pembrolizumab, Abraxane)

        Active, not recruiting
        • Urothelial Carcinoma
        • Ann Arbor, Michigan
          University of Michigan Comprehensive Cancer Center
        Dec 15, 2021

        Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))

        Recruiting
        • Sarcoma
        • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
        • Beijing, China
          Peking University People's Hospital
        Nov 6, 2023

        Sarcoma,Soft Tissue Trial in France (Cobimetinib, Atezolizumab)

        Recruiting
        • Sarcoma,Soft Tissue
        • Angers, France
        • +4 more
        Mar 28, 2022

        Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)

        Not yet recruiting
        • Chemotherapy
        • Radiation Therapy
        • Fuzhou, China
          Fujian Medical University Union Hospital
        Apr 6, 2023

        Cancer Trial in Besancon (Biological samples, Anti PD1/PDL1 treatment)

        Recruiting
        • Cancer
        • Biological samples
        • Anti PD1/PDL1 treatment
        • Besancon, France
          University Hospital of Besançon
        Jul 30, 2021

        Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab

        Recruiting
        • Metastatic Gastric Cancer
        • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
        • Nivolumab Injection
        • Beijing, Beijing, China
          Peking University Cancer Hospital
        Aug 23, 2023

        Lung Cancer Trial in Assiut (Observational Study ( Tissue Biopsy ))

        Completed
        • Lung Cancer
        • Observational Study ( Tissue Biopsy )
        • Assiut, Egypt
          Assiut University
        Oct 18, 2021

        SCLC,Extensive Stage Trial in Changchun (AK104 IV infusion;Chiauranib oral)

        Not yet recruiting
        • SCLC,Extensive Stage
        • AK104 IV infusion;Chiauranib oral
        • Changchun, Jilin, China
          Jilin Province Cancer Hospital
        Aug 16, 2022